Last Updated: July 1, 2026

PROPAFENONE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Propafenone, and what generic alternatives are available?

Propafenone is a drug marketed by Aurobindo Pharma Ltd, Glenmark Pharms Ltd, Mylan, Rising, Sinotherapeutics Inc, Strides Pharma Intl, Twi Pharms, Upsher Smith Labs, Watson Labs Inc, Zydus Lifesciences, Ani Pharms, Aurobindo Pharma, Nesher Pharms, Sun Pharm Industries, and Watson Labs. and is included in sixteen NDAs.

The generic ingredient in PROPAFENONE is propafenone hydrochloride. There are eleven drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the propafenone hydrochloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Propafenone

A generic version of PROPAFENONE was approved as propafenone hydrochloride by WATSON LABS on October 24th, 2000.

  Start Trial

AI Deep Research
Ask!
Questions you can ask:
  • What is the 5 year forecast for PROPAFENONE?
  • What are the global sales for PROPAFENONE?
  • What is Average Wholesale Price for PROPAFENONE?
Summary for PROPAFENONE
US Patents:0
Applicants:15
NDAs:16
Drug Prices: Drug price information for PROPAFENONE
DailyMed Link:PROPAFENONE at DailyMed
Drug patent expirations by year for PROPAFENONE
Drug Prices for PROPAFENONE

See drug prices for PROPAFENONE

Drug Sales Revenue Trends for PROPAFENONE

See drug sales revenues for PROPAFENONE

US Patents and Regulatory Information for PROPAFENONE

Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Strides Pharma Intl PROPAFENONE HYDROCHLORIDE propafenone hydrochloride TABLET;ORAL 075938-002 Oct 17, 2002 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Ani Pharms PROPAFENONE HYDROCHLORIDE propafenone hydrochloride TABLET;ORAL 076550-002 Apr 23, 2004 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Sun Pharm Industries PROPAFENONE HYDROCHLORIDE propafenone hydrochloride TABLET;ORAL 075998-003 Nov 29, 2001 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Zydus Lifesciences PROPAFENONE HYDROCHLORIDE propafenone hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 214184-001 Apr 21, 2021 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Ani Pharms PROPAFENONE HYDROCHLORIDE propafenone hydrochloride TABLET;ORAL 076550-003 Apr 23, 2004 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Zydus Lifesciences PROPAFENONE HYDROCHLORIDE propafenone hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 214184-002 Apr 21, 2021 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Subscribe to access the full database, or Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2026 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2026 - 2027
 NCE-1 Patent Challenge Dates 2026 - 2027
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2026, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links